We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Inotiv Inc (NOTV) NPV

Sell:$10.78 Buy:$11.20 Change: $0.29 (2.72%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$10.78
Buy:$11.20
Change: $0.29 (2.72%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$10.78
Buy:$11.20
Change: $0.29 (2.72%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Contact details

Address:
2701 Kent Ave
WEST LAFAYETTE
47906-1350
United States
Telephone:
+1 (317) 4634527
Website:
https://www.inotivco.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NOTV
ISIN:
US45783Q1004
Market cap:
$274.67 million
Shares in issue:
25.79 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Robert Leasure
    President, Chief Executive Officer, Director
  • Beth Taylor
    Chief Financial Officer, Senior Vice President - Finance
  • John Beattie
    Chief Operating Officer
  • Andrea Castetter
    Senior Vice President, General Counsel, Corporate Secretary
  • Brennan Freeman
    Vice President - Finance, Corporate Controller, Principal Accounting Officer
  • John Sagartz
    Chief Strategy Officer, Director
  • Michael Garrett
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.